Protalix BioTherapeutics, Inc. (PLX) stock
PLXNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 16/3047% below fair value
$3.02+0.14 (+4.86%)
Close on Nov 18, 2026Market cap $243.33MP/E 13.1Yield –
Protalix BioTherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Protalix BioTherapeutics's market cap was $255.04M on Nov 11, 2026, against $152.65M a year earlier. Over the last 5 years it ranged from $34.15M to $255.04M, with a median of $112.96M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $255.04M | +65.2% |
| 2025 | Dec 31, 2025 | $154.36M | +4.5% |
| 2024 | Dec 31, 2024 | $147.64M | +20.4% |
| 2023 | Dec 29, 2023 | $122.64M | +90.5% |
| 2022 | Dec 30, 2022 | $64.37M | +88.5% |
| 2021 | Dec 31, 2021 | $34.15M | -39.2% |
| 2020 | Dec 31, 2020 | $56.17M | +15.4% |
| 2019 | Dec 31, 2019 | $48.66M | -99.6% |
| 2018 | Dec 31, 2018 | $11.29B | +12192.4% |
| 2017 | Dec 29, 2017 | $91.88M | +105.1% |
| 2016 | Dec 30, 2016 | $44.80M | -53.0% |
| 2015 | Dec 31, 2015 | $95.33M | -44.1% |
| 2014 | Dec 31, 2014 | $170.67M | -52.4% |
| 2013 | Dec 31, 2013 | $358.68M | -23.2% |
| 2012 | Dec 31, 2012 | $467.31M | -10.7% |
| 2011 | Jul 29, 2011 | $523.24M | – |
See a number that looks wrong?